Genenta Science S.p.A. (NASDAQ:GNTA – Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 5,500 shares, an increase of 14.6% from the November 30th total of 4,800 shares. Based on an average trading volume of 2,200 shares, the days-to-cover ratio […]
DelveInsight Business Research, LLP: Leptomeningeal Metastases Treatment Market to Register Immense Growth by 2032, Predicts DelveInsight finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) and Genenta Science (NASDAQ:GNTA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Analyst Recommendations This is a breakdown of […]